Published in Cancer Weekly, August 11th, 2009
"The present study was conducted to determine whether interferon-gamma-inducible protein 10/CXCL10 (CXC chemokine ligand 10), one of the potent anti-angiogenic chemokines, can inhibit the growth...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-08-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.